期刊文献+

CT三维容积测量对肝癌介入治疗预后评价的初步研究 被引量:4

The preliminary study of volumetric CT measurement in the prognostic evaluation of patients with advanced primary liver carcinoma treated by transcatheter arterial chemoembolization
原文传递
导出
摘要 目的综合分析影响肝癌患者介入治疗预后的主要因素,重点探讨肝癌的CT三维形态学对生存率的影响。方法对经过介入治疗的166例肝癌患者进行回顾性分析,所有患者术前及术后4周至2个月行CT扫描,明确术前肿瘤的容积、肿瘤与肝脏容积百分比(瘤肝比)等形态学特征,统计患者的一般资料和临床资料,并随访患者生存期。应用SPSS10.0统计分析软件,先进行各变量对生存率影响单因素分析,再对单因素分析有意义的变量行多因素Cox回归分析,采用Kaplan-Meier法计算累积生存率,log-rank检验方法检验2组之间的生存曲线有无差别。结果全组总体6个月及1、2、3年累积生存率分别为:78.54%(125/160)、47.23%(62/141)、23.68%(19/123)、14.09%(5/113);中位生存期为12个月。单因素及多因素Cox回归分析对预后影响均有意义的变量有:瘤肝比、门静脉癌栓、治疗次数及治疗后甲胎蛋白变化。瘤肝比0~25%及26%~50%的患者与51%~70%的患者相比,前2组生存率较后者明显增高,3组中位生存期分别为18、12、7个月;瘤肝比>70%的肝癌患者介入疗效极差,中位生存期仅6个月。结论(1)肝癌的CT形态学特征对介入治疗预后的影响能作出客观的评价。(2)CT三维容积测量肝癌容积及瘤肝比较二维测量能更准确地体现肝癌大小对预后的影响,瘤肝比是影响肝癌介入治疗预后的具有统计学意义的指标。 Objective To analyze those major factors affecting the prognosis of primary liver carcinoma(PLC) patients treated by transcatheter arterial chemoembolization (TACE)and put emphasis on the value of volumetric CT measurement on the survival rate. Methods 166 PLC patients treated with TACE were involved in this retrospective study. The hepatic CT of all patients was performed before TACE and in 4 weeks to 2 months after TACE. The tumor volume, tumor to liver volume ratio(TFLVR) before TACE and the tumor regression rate , lipiodol(LP) retention after TACE were measured. The clinical data and general data of the patients were recorded. All patients were followed up by telephone or clinic. Statistical analysis was performed by SPSS 10.0 statistical software. The prognostic influence of the following parameters was evaluated with univariable analysis. Then multivariate Cox regression analysis model was used to analyze those factors affecting the prognosis to avoid any confounding interaction between them. The cumulative survival time was calculated according to the Kaplan-Meier method. The prognosis influence of the following parameters was analyzed by using of the log-rank tests. Results The overall cumulative survival rates for 6, 12,24 and 36 months were 78.54% ( 125/160), 47.23% (62/141), 23.68% (19/123) and 14.09% (5/ 113) respectively. The median survival time was 12 months. Univariate analysis and multivariate analysis showed 4 parameters were significant prognostic factors. They were TFLVR, portal cancerous thrombus, times of treatment and decrease in AFP concentration after treatment. Survival time of patients of which TTLVR was 0-25% and 50% was more prolonged than that of which TFLVR was 51%-70% ,The median survival time was 18 months,12 months,7 months respectively. It was not suitable for TACE when TFLVR was more than 70% because its median survival time was only 6 months. Conclusion ( 1 ) Morphologic CT parameters can have objective evaluation to the prognosis factors of
出处 《中华放射学杂志》 CAS CSCD 北大核心 2006年第11期1170-1174,共5页 Chinese Journal of Radiology
基金 安徽省教育厅自然科学基金资助项目(2000jl128zc)
关键词 肝细胞 体层摄影术 X线计算机 结果评价(卫生保健) 回归分析 Carcinoma, hepatocellular Tomography, X-ray computed Outcome assessment (Heith care) Regression analysis
  • 相关文献

参考文献11

  • 1Van Hoe L, Van Cutsem E, Vergote 1, et al. Size quantification of liver metastases in patients undergoing cancer treatment:reproducibility of one-, two-, and three-dimensional measurements determined with spiral CT. Radiology, 1997, 202:671-675. 被引量:1
  • 2涂蓉,张阳德.CT肝脏容积测量及其临床应用[J].国外医学(临床放射学分册),2002,25(3):180-183. 被引量:2
  • 3Prasad SR, Jhaveri KS, Saini S, et al. CT tumor measurement for therapeutic response assessment: comparison of unidimensional,bidimensional, and volumetric techniques initial observations.Radiology, 2002, 225: 416-419. 被引量:1
  • 4杨秉辉,夏景林.原发性肝癌的临床诊断与分期标准[J].中华肝脏病杂志,2001,9(6):324-324. 被引量:1011
  • 5Vogl TJ, Trapp M, Schroeder H, et al. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Radiology, 2000,214:349-357. 被引量:1
  • 6刘嵘,王建华,周康荣,颜志平,程洁敏,钱晟,刘清欣,龚高全.肝动脉化疗栓塞治疗原发性肝癌中碘油沉积良好患者疗效观察[J].介入放射学杂志,2001,10(4):212-214. 被引量:42
  • 7许敏,吴在德,陈孝平,吴华.不同方法测定肝脏体积的实验与临床研究[J].肝胆外科杂志,1994,2(4):204-207. 被引量:7
  • 8贾雨辰,刘崎,贺佳,王振堂,王飞,陈栋,孙飞,田建明,叶华,陆建平.Cox模型对肝癌预后因素的分析[J].中华放射学杂志,1996,30(2):80-84. 被引量:29
  • 9Mondazzi L, Botelli R, Brambilla G, et al. Transcatheter oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology, 1994, 19 :1115-1123. 被引量:1
  • 10Farinati F, Maria ND, Marafin C, et al. Unresectable hepatocellular carcinoma in cirrhosis: survival, prognostic fator, and unexpected side effects after transcatheter arterial chenmoembolization. Dig Dis Sci, 1996, 41:2332-2339. 被引量:1

二级参考文献33

  • 1颜志平,周康荣.碘油完全充填肝癌病灶的CT与肝动脉造影比较研究[J].介入放射学杂志,1994,3(2):72-75. 被引量:10
  • 2滕皋军,何仕成,郭金和,蔡锡类,高广如,南正银,谢秀华.肝动脉栓塞术后Ⅱ期肝癌切除(附10例切除标本的病理研究)[J].中华放射学杂志,1994,28(9):597-600. 被引量:15
  • 3贾雨辰,中国医学影像学杂志,1994年,2卷,56页 被引量:1
  • 4林贵,中华放射学杂志,1992年,26卷,311页 被引量:1
  • 5刘崎,中华放射学杂志,1991年,25卷,152页 被引量:1
  • 6Lin XZ, Sun YN, Liu YH, et al. Liver volume in patients with or without chronic liver diseases. Hepato Gastroenterology, 1998, 45(4): 1069-1074 被引量:1
  • 7Henderson JM, Steven BH, Horowitz J, et al. Measurement of liver and spleen volume by computed tomography. Radiology, 1981, 141(2): 525-527 被引量:1
  • 8Glombitza G, Lamade W, Deniris AM, et al. Virtual planning of liver resections: image processing, visualization and volumetric evaluation. Int J Med Inf, 1999, 53(2-3): 225-237 被引量:1
  • 9Sandrasegaran K, Kwo PW,Girolamo DD, et al. Measurement of liver volume using spiral CT and the curved line and cubic spline algorithms: reproducibility and interobserver variation. Abdom Imaging, 1999, 24(1): 61-65 被引量:1
  • 10Matsui Y, Tu W, Kitade H, et al. Hepatocyte volume as an indicator of hepatic functional reserve in cirrhotic patients with liver tumors.J Gastroenterol Hepatol, 1996, 11(6): 540-545 被引量:1

共引文献1079

同被引文献14

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部